ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Ovarian Cancer
Breast Cancer
Ovarian Epithelial Carcinoma
Triple Negative Breast Cancer
Adenocarcinoma

Endometrial Cancer trials near London, England, GBR:

Atezolizumab Trial in Endometrial Cancer - AtTEnd

Phase Ia study of Atezolizumab (NCT01375842) monotherapy in relapsed endometrial cancer were reported as abstract at ASCO 2017. Fif...

Active, not recruiting
Endometrial Cancer
Drug: Paclitaxel
Drug: Carboplatin

Phase 3

Mario Negri Institute for Pharmacological Research

London, United Kingdom and 92 other locations

The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. E ...

Enrolling
Endometrial Cancer
Drug: Megestrol Acetate
Drug: Durvalumab

Phase 2, Phase 3

Leiden University Medical Center (LUMC)

London, United Kingdom and 13 other locations

Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Doxorubicin

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

London, London, City Of, United Kingdom and 121 other locations

The COPELIA trial is evaluating two new tablet medications in endometrial cancer for the first time. It will include 129 women aged ...

Active, not recruiting
Endometrial Neoplasms
Carcinosarcoma
Drug: Paclitaxel
Drug: Olaparib

Phase 2

University of Manchester

London, United Kingdom and 14 other locations

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

Tesaro
Tesaro

London, United Kingdom and 162 other locations

choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...

Active, not recruiting
Endometrial Neoplasms
Drug: Pembrolizumab
Drug: Doxorubicin

Phase 3

Eisai
Eisai

London, United Kingdom and 168 other locations

Status recently updated

durvalumab (MEDI4736) in patients with relapsed gynaecological cancers to assess the response in groups of patients selected based on their ...

Unknown
Enrolling
Gynaecological Cancers
Drug: Durvalumab
Drug: Ceralasertib

Phase 2

Institute of Cancer Research, United Kingdom

London, United Kingdom and 8 other locations

This study is an open-label, Phase 1, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) profile...

Enrolling
Endometrial Cancer
Advanced Cancer
Drug: Balstilimab
Drug: Botensilimab

Phase 1

Agenus
Agenus

London, United Kingdom and 18 other locations

TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...

Enrolling
Endometrial Cancer
Gastric Cancer
Drug: Carboplatin
Drug: Leucovorin LV

Phase 2

AstraZeneca
AstraZeneca

London, United Kingdom and 92 other locations

-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Lower Esophageal Cancer
Drug: cabozantinib
Drug: atezolizumab

Phase 1, Phase 2

Exelixis
Exelixis

London, United Kingdom and 123 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems